Early pharmacological intervention in acute promyelocytic leukemia: can we still improve outcomes?

Expert Rev Hematol. 2026 May 15:1-4. doi: 10.1080/17474086.2026.2672111. Online ahead of print.

Authors

Håkon Reikvam^{1

2}, Sona Vardanyan³, Tor Henrik Andersson Tvedt^{4

5}

Affiliations

¹ K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.
² Department of Medicine, Haukeland University Hospital, Bergen, Norway.
³ Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
⁴ Department of Hematology, Oslo University Hospital, Oslo, Norway.
⁵ Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

PMID: 42095625
DOI: 10.1080/17474086.2026.2672111

No abstract available

Keywords: Acute promyelocytic leukemia; antihemorrhagica; antithrombotica; bleeding; coagulopathy; thrombosis.

Publication types

Editorial